The future of heart health with AI-powered devices and treatment approaches
March 28, 2025 | #MedscapeEducation #AICardiology
Artificial intelligence (AI) is revolutionising the field of cardiology, offering new hope for patients with cardiovascular disorders. AI is no longer futuristic, it’s a real-world tool, transforming patient care and outcomes.
One of the key areas where AI is making a significant impact is in the early detection of cardiovascular diseases (CVD). Traditional methods often fail to diagnose CVD before symptoms appear, leading to delayed treatment and poorer outcomes. AI, however, can analyse vast amounts of data from electrocardiograms (ECGs) and other diagnostic tools to identify early signs of heart disease that might be missed by human eyes, which improves diagnostic accuracy and patient outcomes.1
Personalising cardiology treatment
AI also plays a crucial role in personalising treatment plans. By analysing patient data, AI can help doctors tailor treatments to individual needs, ensuring that each patient receives the most effective therapy. This personalised approach is particularly beneficial in managing complex conditions like heart failure, where treatment needs to be adjusted frequently based on the patient’s response.
AI-powered digital devices
The use of wearable and portable devices is another exciting development in AI cardiology. These devices, such as smartwatches and portable ECG monitors, enable continuous monitoring of heart health, providing real-time data to both patients and healthcare providers. This continuous monitoring can lead to early intervention and better management of chronic conditions, ultimately reducing hospitalisations and improving quality of life.2
Effective AI integration in healthcare
Despite these advancements, there are still significant challenges to overcome when it comes to getting healthcare professionals confident about realising the full potential of these AI-powered technologies and tools. Healthcare professionals already face an exponential rise in medical information which is doubling at least every 73 days.3 Furthermore, the integration of AI into healthcare systems requires robust data privacy measures and regulatory oversight to ensure patient safety and data security.4
Fully and safely realising AI capabilities
AI is poised to transform cardiology by enhancing early disease detection, personalising treatment and improving overall care quality. As technology continues to evolve, the potential for AI to improve outcomes for patients with cardiovascular disorders is immense; however, ongoing education is needed in its widespread adoption to ensure it is being utilised to its full capabilities. The future of cardiology is bright, with AI leading the way towards more efficient, accurate and personalised care.
[1] Attia, Z.I., et al. (2019). ‘An artificial intelligence-enabled ECG algorithm for the identification of patients with atrial fibrillation during sinus rhythm: a retrospective analysis of outcome prediction’, The Lancet, 394(10201), pp. 861–867. doi: 10.1016/S0140-6736(19)31721-07.
[2] Khunte, A., et al. (2023). ‘Detection of left ventricular systolic dysfunction from single-lead electrocardiography adapted for portable and wearable devices’, NPJ Digital Medicine, 6(1), p. 124. doi: 10.1038/s41746-023-00869-w.
[3] Koenig, H.G. (2012) ‘Religion, spirituality, and health: The research and clinical implications’, International Scholarly Research Notices, 2012, pp. 1–33. doi: 10.5402/2012/278730.
[4] Chustecki M. Interact J Med Res. 2024;13:e53616; Davenport T, et al. Future Healthc J. 2019;6:94-98; Khera R, et al. J Am Coll Cardiol. 2024;84:97-114; Khera R, et al. JAMA. 2023;330:2255-2257.
This content was provided by Medscape Education
Company Details
Latest Content from Medscape Education
Shifting the Paradigm: A New Era for Parkinson’s Care
In this episode of “Hear From Her:” Hear from two leaders at the forefront of a much-needed change in how Parkinson’s is understood, diagnosed, and treated.
World Orphan Drug Congress 2025 in Amsterdam
Medscape Education will make its debut at the World Orphan Drug Congress (WODC) 2025, taking place in Amsterdam, the Netherlands, October 28-29.
Medscape Education: Pioneering Pathways at ESMO 2025
Medscape Oncology will be pioneering pathways at the 2025 ESMO congress taking place in Berlin, Germany this October.
Game On: Medscape Education Golfs for a Cause
Medscape Education is proud to stand alongside the National Kidney Foundation (NKF) as a sponsor of one of the nation’s most impactful charity events benefiting patients living with kidney disease,...
Innovation in Action at AAFP FMX 2025
This year, Medscape Education is redefining the live learning experience at AAFP FMX 2025. With 8 groundbreaking, accredited symposia, we are proud to be at the heart of the meeting,...
Shifting the Paradigm: A New Era for Parkinson’s Care
In this episode of “Hear From Her:” Hear from two leaders at the forefront of a much-needed change in how Parkinson’s is understood, diagnosed, and treated.
Global Healthy Living Foundation and Medscape Education Join Forces to Bridge the Gap Between Patients and Providers with Immunology Education
UPPER NYACK, N.Y.--(BUSINESS WIRE)--The Global Healthy Living Foundation (GHLF) today announced a new partnership with Medscape Education to advance patient-centered innovation within the Immunology Learning Nexus (Nexus), Medscape’s flagship multi-year...
Breakthrough Alzheimer’s Therapies Drive Early Detection Rates While Exposing Deep Treatment Disparities
Analysis from Komodo Health and Medscape Education shows cognitive screening up 10% and biomarker testing up 23%, yet significant disparities persist in detection for women and treatment access for Black...
Virtual Practice, Real Results: The Power of Virtual Patient Simulation
Simulation has never been more vital in medicine than it is today. As increasing numbers of physicians turn to large language models for clinical answers1, the real differentiator isn’t just...
A New Destination for Oncology Education
Medscape Oncology is pleased to announce the launch of a groundbreaking new learning space designed to provide education across tumor types and oncology disciplines: PIONEER – PrecIsion Oncology: Navigating EvidEnce...